Direxion Daily Healthcare Bull 3X ETF
$129.88−3.02 (−2.28%)
- Expense ratio
- 0.94%
- Fund size
- $168M
- 1Y return
- +68.9%
- Yield · Last 12 months
- 0.95%
- Holdings
- 71
- Volume · 30D
- 0.1M sh
- NAV per share
- $129.44
- 52W range
The ETF.net CURE Grade
Score 71 of 100 sits in the A band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 88Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 67Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.CScore 48Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.Not scoredDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.CScore 51Category rank
Our read on CURE
AHealthcare is the market's defensive sector. CURE straps three-times daily leverage to it, aiming for 300% of the Health Care Select Sector Index's daily move across drugmakers, insurers and device names. A trading tool with a one-day clock, running since 2011.
The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the Health Care Select Sector Index.
Why people hold it
- Fee is 0.94%, below what the typical leveraged bull fund charges. On a geared product you rent by the day, that gap is real money.
- One job, plainly stated: 300% of the daily performance of the Health Care Select Sector Index, roughly 70 large-cap US healthcare names. No stock picking, no style drift.direxion.com
- Trading since 2011, a long tenure for a geared sector fund, and one of the stronger builds among leveraged bull ETFs.
Worth knowing
- The leverage resets every day. Hold past the closing bell and compounding takes over, so multi-day results can land far from 3x the index over that stretch.
- Gearing is symmetrical. A bad day for healthcare, drug-pricing headlines or an FDA surprise, comes through roughly tripled.
- One sector, about 70 stocks, then leverage on top. Concentration and gearing stack, so daily swings dwarf a broad-market fund's.
CURE Holdings
- Stocks
- 71
- 87%
- IXV SWAP ASSET LEG (IXVBCL)
Sectors
- Health Care99.3%
- Technology0.7%
Geography
- United States97.71%
- Ireland2.29%
CURE Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | CURE |
|---|---|
| Year to date | +20.0% |
| 1 month | −8.1% |
| 3 months | +39.0% |
| 1 year | +68.9% |
| 3 years | +14.5% |
| 5 years | +3.4% |
| 10 years | +15.6% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | CURE |
|---|---|---|
| 2026 YTD | +20.0% | |
| 2025 | +22.5% | |
| 2024 | −8.5% | |
| 2023 | −9.4% | |
| 2022 | −20.5% | |
| 2021 | +88.3% | |
| 2020 | +4.9% |
CURE in the news
ETF.net Research hasn’t filed on CURE yet — coverage lands here as it’s written.
CURE Dividends
- 0.95%
- $1.26
- $0.37 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 23, 2026 | Jun 30, 2026 | $0.37 |
| Mar 24, 2026 | Mar 31, 2026 | $0.28 |
| Dec 23, 2025 | Dec 31, 2025 | $0.29 |
| Sep 23, 2025 | Sep 30, 2025 | $0.31 |
| Jun 24, 2025 | Jul 1, 2025 | $0.31 |
| Mar 25, 2025 | Apr 1, 2025 | $0.35 |
| Dec 23, 2024 | Dec 31, 2024 | $0.12 |
| Sep 24, 2024 | Oct 1, 2024 | $0.33 |
| Jun 25, 2024 | Jul 2, 2024 | $0.27 |
| Mar 19, 2024 | Mar 26, 2024 | $0.36 |
| Dec 21, 2023 | Dec 29, 2023 | $0.57 |
| Sep 19, 2023 | Sep 26, 2023 | $0.45 |
CURE Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 42.9%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.38
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −52.3%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.27
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
CURE Cost
- The middle half of 3x Leveraged Long funds
- Median 0.98%
3 of the 30 3x Leveraged Long funds charge less.